In the Face of Crisis
November 30, 2020
Sitting Down With… Elaine O’Hara, Chief Commercial Officer, Sanofi Pasteur, US (Swiftwater, PA)
1 min read

November 30, 2020
Sitting Down With… Elaine O’Hara, Chief Commercial Officer, Sanofi Pasteur, US (Swiftwater, PA)
1 min read
November 28, 2020
Aiming for technologies that can make medicines in space or on Mars can also help us with problems closer to home, such as challenges with cold chain and getting medicines to remote locations
1 min read
November 27, 2020
Is it possible to design a bioreactor that can function in microgravity?
1 min read
November 27, 2020
Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities
1 min read
November 26, 2020
How can we eradicate this fatal tropical disease once and for all?
1 min read
November 26, 2020
Environmental sustainability and “big picture thinking” should be key considerations when selecting solvents for scale-up
1 min read
November 25, 2020
What happens after COVID-19?
1 min read
November 25, 2020
A $4-billion acquisition, a key finding for sarcopenia drug development, and algorithmic efficiency… What’s new in advanced medicine?
1 min read
November 20, 2020
1 min read
November 19, 2020
Ever since the “bird flu” outbreaks of the mid-2000s, public health experts have been concerned about an influenza pandemic to rival the 1918 Spanish Flu. Now, blindsided by a less expected beast, can we transfer lessons on pandemic preparedness from flu to COVID-19? We caught up with Russell Basser, Head of R&D at flu vaccine manufacturer Seqirus to find out more about the past, present, and future of vaccine production – and how COVID-19 changes the outlook.
1 min read
False
False